2021 annual financial guidance
Company: Core Scientific
The claim, verbatim
Core Scientific expected 2021 revenue of $515-545 million, net income of $50-60 million, and adjusted EBITDA of $225-235 million.
Source (primary)
Core Scientific, Inc. — Entry #1842: Adversary case 22-03345 (RECAP (purchased via PACER), court_filing)
View cached copy (2026-09-26)Live source ↗
Quote: “We expect 2021 revenue to be $515 million to $545 million, net income of $50 million to $60 million and adjusted EBITDA of $225 million to $235 million.”
How we checked this
This claim has not yet been checked assertion-by-assertion against its source. It carries a cited source and quote, but the deeper check has not run. When it does, the result appears here whatever it says.
Additional evidence
confirms Core Scientific, Inc. — Entry #1842: Adversary case 22-03345
Quote: “We expect 2021 revenue to be $515 million to $545 million, net income of $50 million to $60 million and adjusted EBITDA of $225 million to $235 million.”